The Middle East and Africa botulinum toxin market size is expected to reach US$ 453.55 million by 2030 from US$ 172.57 million in 2022. The market is estimated to record a CAGR of 12.8% from 2022 to 2030.
Market Insights and Analyst View:
Botox injections block chemical signals from nerves that cause muscle contraction. The injections relax the facial muscles that cause frown lines and other facial wrinkles. Botox is a drug developed from a toxin produced by the bacterium Clostridium botulinum. There are various types of botulinum toxin, with types A and B being commonly used for medical and cosmetic purposes.
Botulinum toxin is used for the treatment of various medical conditions, including chronic migraines, muscle spasms, and certain neurological disorders. It is also widely known for its cosmetic applications, particularly in the form of Botox injections, to reduce the appearance of facial wrinkles and fine lines. In medical and cosmetic settings, botulinum toxin is injected directly into specific muscles. The toxin blocks nerve signals in the injected muscles, causing temporary muscle paralysis. The effects of botulinum toxin are temporary, typically lasting for a few months. Repeat injections are often necessary to maintain the desired results.
While botulinum toxin is generally considered safe when administered by medical professionals in appropriate doses, there can be side effects and risks. Common side effects include temporary bruising and muscle weakness. It is crucial for individuals considering botulinum toxin treatments to consult with qualified healthcare professionals to assess suitability and discuss potential risks and benefits. Additionally, regulations regarding the use of botulinum toxin may vary by country and region.
The Middle East & Africa botulinum toxin market is growing rapidly due to a number of factors, such as increasing disposable incomes in the Middle East, rising awareness regarding the benefits of botulinum toxin, growing prevalence of neurological disorders, and increasing applications of botulinum toxin in the treatment of various diseases. The market is also expected to benefit from the development of new and innovative botulinum toxin products and applications. However, side effects associated with the botulinum toxin hamper the Middle East and Africa botulinum toxin market growth.
Growth Drivers and Challenges:
Rising Awareness Regarding Benefits of Botulinum Toxin Drives Middle East and Africa Botulinum Toxin Market Growth
People in the Middle East are willing to spend money on aesthetic procedures due to a rise in disposable incomes. Botulinum toxin injections are a popular aesthetic procedure as they are relatively quick, easy, and effective. People in the Middle East are becoming more aware of the benefits of botulinum toxin injections, both for aesthetic and therapeutic purposes. Botulinum toxin injections can be used to treat wrinkles, frown lines, and crow's feet. Botulinum toxin is an effective and safe treatment for various neurological disorders, including spasticity, dystonia, and migraine headaches. The rising prevalence of neurological disorders in the Middle East drives demand for botulinum toxin injections. Botulinum toxin injections are increasingly being used to treat hyperhidrosis or excessive sweating. Hyperhidrosis can be a debilitating condition that can affect a person's social and professional life. Botulinum toxin injections can provide effective relief from hyperhidrosis symptoms. Minimally invasive procedures are becoming increasingly popular, as they are associated with less pain, scarring, and recovery time than traditional surgical procedures. Botulinum toxin injections are minimally invasive procedures that can be performed in a doctor's office. Owing to the factors mentioned above, the Middle East and Africa botulinum toxin market is expected to grow in the coming years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Middle East and Africa Botulinum Toxin Market: Strategic Insights
Market Size Value in US$ 172.57 million in 2022 Market Size Value by US$ 453.55 million by 2030 Growth rate CAGR of 12.8% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Middle East and Africa Botulinum Toxin Market: Strategic Insights
| Market Size Value in | US$ 172.57 million in 2022 |
| Market Size Value by | US$ 453.55 million by 2030 |
| Growth rate | CAGR of 12.8% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Segmentation and Scope:
The “Middle East & Africa Botulinum Toxin Market” is segmented on the basis of product, application, end-user, and Country.
Based on product, the Middle East and Africa botulinum toxin market is segmented into Botox, Dysport, Xeomin, and others. The Botox segment held the largest market share in 2022 and is expected to retain its dominance during the forecast period. By application, the market is bifurcated into medical and aesthetic. The medical segment held a larger market share in 2022. However, the aesthetic segment is anticipated to register a significant CAGR during the forecast period. The botulinum toxin market, by end-user, is segmented into hospitals and clinics, specialty and dermatology clinics, and others. The specialty and dermatology clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
The medical segment led the Middle East and Africa botulinum toxin market in 2022 and is expected to retain its dominance during the forecast period. Botulinum toxin is widely used to treat medical conditions such as chronic migraine, adult spasticity, pediatric spasticity, and others. For migraine conditions, onabotulinumtoxin A is a prescription medication injected into the muscle with clinical effects such as preventing headaches among adults with chronic migraine.
Botulinum toxin is one of the most versatile agents in the aesthetic field. It has been used for numerous applications, such as the treatment of glabellar and forehead lines, eyebrow repositioning, and periorbital wrinkles.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Regional Analysis:
Based on country, the Middle East and Africa botulinum toxin market is segmented into Saudi Arabia, the UAE, South Africa, Lebanon, Oman, Jordan, Qatar, Kuwait, Bahrain, and the Rest of the Middle East & Africa. Saudi Arabia held the largest market share, followed by the UAE.
Saudi Arabia is one of the largest markets in the Middle East and Africa regarding population and economy. In recent years, there has been an increase in the number of cosmetic procedures, either surgical or non-surgical. According to a study conducted by the International Society of Aesthetic Plastic Surgeons, Saudi Arabia ranks 22nd among the top 25 countries with the highest rates of cosmetic procedures in the world. Acceptance of less invasive procedures such as botulinum toxin, dermal fillers, laser, and chemical peels increased among middle-aged women to have a natural look without significant downtime.
Furthermore, increasing product approvals for treating glabellar lines is expected to impact the Middle East and Africa Botulinum toxin market positively. In October 2022, Daewoong Pharmaceutical announced that it had obtained product approval from the Saudi Arabian and Ukrainian governments for Nabota, a botulinum toxin (BTX) product.
Therefore, the factors mentioned above fuel the growth of the Middle East and Africa Botulinum toxin market in Saudi Arabia.
Competitive Landscape and Key Companies:
Organic and inorganic growth strategies have characterized developments in the Middle East and Africa botulinum toxin market. Various companies focus on organic growth strategies such as launches, expansion, enhancement, and relocation. Inorganic growth strategies witnessed in the market were mergers & acquisitions, partnerships, and collaborations. These activities have paved the way for the expansion of businesses and the customer base of Middle Eastern and African botulinum toxin market players.
- In February 2022, Merz Therapeutics announced that it will expand its strategic partnership with Vensica Therapeutics as the Merz Group invests up to US$3 million in the Israeli start-up. This investment follows the strategic license and collaboration agreement signed in 2021 to utilize Merz’s botulinum neurotoxin A (XEOMIN) for the innovative ultrasound-assisted delivery catheter of Vensica. Merz is thus executing its contractually agreed option to participate in Vensica’s Series C financing round and invest further in the start-up.
- In August 2021, Merz Therapeutics and the Israeli start-up Vensica Therapeutics Ltd., a urology company, announced that they have entered into a strategic license and collaboration agreement to deliver botulinum neurotoxin A (XEOMIN) to the bladder wall by using Vensica’s innovative ultrasound-assisted delivery catheter. By this, Merz Therapeutics becomes the exclusive toxin supplier of any needleless application for urological indications, such as overactive bladder, neurogenic bladder, interstitial cystitis, and other urology indications.
Company Profiles
- Merz Pharma GmbH & Co KGaA
- AbbVie Inc
- Revance Therapeutics Inc
- Ipsen SA
- Medytox Inc
- Evolus Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
- Gufic
- Metabiologics, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Answer: - The Middle East and Africa botulinum toxin market by application is segmented into medical and aesthetic. The medical segment held the largest share of the Middle East and Africa Botulinum Toxin market, and it is anticipated to register the highest CAGR.
Answer: The factors that are driving the growth of market are growth are increasing disposable incomes in the Middle East, increasing awareness of the benefits of botulinum toxin, growing prevalence of neurological disorders, and increasing applications of botulinum toxin in the treatment of various diseases.
Answer: - The botulinum toxins market majorly consists of the players such as Merz Pharma GmbH & Co KGaA, AbbVie Inc, Revance Therapeutics Inc, Ipsen SA, Medytox Inc, Evolus Inc, Hugel Inc, Lanzhou Institute of Biological Products Co Ltd, Gufic, and Metabiologics, Inc.
Answer: - The Middle East and Africa botulinum toxin market by product is segmented into Botox, Dysport, Xemoin, and others. The Botox segment held the largest share of the Middle East and Africa Botulinum Toxin market, and it is anticipated to register the highest CAGR.
Answer: Botox injections block chemical signals from nerves that cause muscle contraction. The Botox injections relax the facial muscles that cause frown lines and other facial wrinkles. Botox is a drug developed from a toxin produced by the bacterium Clostridium botulinum. There are various types of botulinum toxin, with types A and B being commonly used for medical and cosmetic purposes.
The List of Companies - Middle East and Africa Botulinum Toxin Market
- Merz Pharma GmbH & Co. KGaA
- AbbVie Inc.
- Revance Therapeutics Inc.
- Ipsen SA
- List Biological Labs Inc.
- Medytox Inc.
- Evolus Inc.
- Hugel Inc.
- Lanzhou Institute of Biological Products Co. Ltd.
- Supernus Pharmaceuticals
- Gufic
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa Botulinum Toxin Market
Dec 2023
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2023
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2023
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2023
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2023
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Dec 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Dec 2023
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)